Status:
COMPLETED
Hypophosphatemia Deleteriously Affects Outcome of Septic Shock Patients Admitted to ICU
Lead Sponsor:
Ayman Anis Metry
Conditions:
Effect of Hypophosphatemia on Septic Patients
Eligibility:
All Genders
18-85 years
Brief Summary
Patients with severe sepsis/septic shock complicated by hypophosphatemia are at high risk of developing morbidities other than that underlying sepsis and more vulnerable to higher mortality rate. Thus...
Detailed Description
The current study was started since June 2018 till Jan 2020 after approval of the study protocol by the Local Ethical Committee. The study intended to include all patients admitted to ICU with or deve...
Eligibility Criteria
Inclusion
- All patients admitted to ICU were eligible to evaluation for demographic and clinical data including hemodynamic data.
- Disease severity and its impact on body organs were evaluated using acute physiology and chronic health evaluation II score (APACHE II) (20) and SOFA (18) scores.
Exclusion
- Maintenance on immunodepressent therapy.
- Severe hemorrhagic shock.
- Pregnancy
- Refusal of nearest relative to sign the written concept for study participation.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT04455113
Start Date
June 1 2018
End Date
June 1 2020
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University hospitals
Cairo, Egypt